Long-Term Outcomes of Obstetric Brachial Plexus Injury: A Single-Center Experience.
Autor: | Kurt F; Pediatrics, Duzce University, Duzce, TUR., Erdem Sultanoglu T; Physical Medicine and Rehabilitation, Duzce University, Duzce, TUR. |
---|---|
Jazyk: | angličtina |
Zdroj: | Cureus [Cureus] 2024 Nov 15; Vol. 16 (11), pp. e73782. Date of Electronic Publication: 2024 Nov 15 (Print Publication: 2024). |
DOI: | 10.7759/cureus.73782 |
Abstrakt: | Obstetric brachial plexus injury (OBPI) is an important preventable complication of the birth process. While most cases recover in the early period, a substantial number result in sequelae. Despite established risk factors, there are cases that occur without any apparent risk factors. Our study aims to identify prenatal risk factors by examining OBPI cases born in our hospital and to provide insights into the prognosis of the disease by comparing cases with panplexopathy to those without. We included 31 cases followed for OBPI in our hospital. Risk factors related to the infant and the mother were investigated. The range of motion (ROM) measurements of the affected upper extremity joints, muscle strength, atrophy, and scoliosis status were evaluated. Of the cases, 71% were girls, and 61.3% had left-sided involvement. Additionally, 84.1% had risk factors, with oxytocin administration being the most frequently identified risk factor. In our study, we compared cases with panplexopathy to those without. Shoulder abduction, shoulder adduction, wrist flexion, and wrist extension restrictions were significantly more common in cases with panplexopathy. Furthermore, muscle atrophy was significantly more frequent in the panplexopathy group. Since OBPI is a preventable injury, identifying risk factors is crucial. However, there are conflicting results regarding the most significant risk factor. Our study highlights that oxytocin administration is a very important risk factor for OBPI. We found that cases with panplexopathy had a worse prognosis, with more frequent ROM limitations and muscle atrophy. Competing Interests: Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Düzce University Faculty of Medicine Ethics Committee issued approval 2024/133. This research involving human subjects complied with all relevant national regulations and institutional policies and was conducted in accordance with the tenets of the Helsinki Declaration. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work. (Copyright © 2024, Kurt et al.) |
Databáze: | MEDLINE |
Externí odkaz: |